Literature DB >> 20838282

The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance.

Hyun-Yeol Nam1, Seong-Jang Kim, In-Joo Kim, Bum-Soo Kim, Kyoungjune Pak, Keunyoung Kim.   

Abstract

OBJECTIVE: The purpose of this study was to investigate correlations between diffuse splenic FDG uptake and hematological and inflammatory parameters to clarify the significance of splenic FDG uptake on PET/CT images.
METHODS: We retrospectively analyzed the consecutive records of F-18 FDG PET/CT scans and selected 31 patients with diffuse splenic FDG uptake as patient group. A total of 25 patients who underwent F-18 FDG PET/CT scans for simple health checkup were enrolled as control group. ROIs were placed on the liver and spleen to measure maximal standardized uptake value (SUVmax). The spleen SUVmax was divided by the liver SUVmax to calculate the spleen/liver ratio. The correlations between the S/L ratio and various hematological parameters were evaluated.
RESULTS: The S/L ratio was positively correlated with serum C-reactive protein level, white blood cell count, and neutrophil count and negatively correlated with hemoglobin, hematocrit, and red blood cell count. Under multiple regression analysis, the Hb level and the C-reactive protein level were the significant predictors for diffuse splenic FDG uptake.
CONCLUSION: In conclusion, our study suggests that concurrent inflammation or anemia at the time of PET/CT study could be one of various causes of diffuse splenic FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20838282     DOI: 10.1097/RLU.0b013e3181ef0905

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  15 in total

1.  Diffusely Increased Splenic Fluorodeoxyglucose Uptake in Lung Cancer Patients.

Authors:  Gül Ege Aktaş; Ali Sarıkaya; Selin Soyluoğlu Demir
Journal:  Turk Thorac J       Date:  2017-01-01

2.  Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.

Authors:  Romain-David Seban; John S Nemer; Aurélien Marabelle; Randy Yeh; Eric Deutsch; Samy Ammari; Antoine Moya-Plana; Fatima-Zohra Mokrane; Robyn D Gartrell; Grace Finkel; Luke Barker; Amélie E Bigorgne; Lawrence H Schwartz; Yvonne Saenger; Caroline Robert; Laurent Dercle
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-25       Impact factor: 9.236

3.  Relationship between reticuloendothelial systems' FDG uptake level and clinicopathological features in patient with invasive ductal breast cancer.

Authors:  Ertan Şahin; Umut Elboğa
Journal:  Radiol Med       Date:  2017-06-09       Impact factor: 3.469

4.  Systemic Immune Response to Vaccination on FDG-PET/CT.

Authors:  Mark Mingos; Stephanie Howard; Nicholas Giacalone; David Kozono; Heather Jacene
Journal:  Nucl Med Mol Imaging       Date:  2015-12-09

5.  Abdominal aortitis on PET CT: A case report and review of the literature.

Authors:  J Foley; D Mullan; H Mohan; K Schmidt
Journal:  Int J Surg Case Rep       Date:  2015-03-24

6.  Malaria masquerading as relapse of Hodgkin's lymphoma on contrast enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: A diagnostic dilemma.

Authors:  Sunil Jeph; Kamia Thakur; Shamim Ahmed Shamim; Ajay Aggarwal
Journal:  Indian J Nucl Med       Date:  2014-04

7.  Factors Associated with Diffusely Increased Splenic F-18 FDG Uptake in Patients with Cholangiocarcinoma.

Authors:  Keunyoung Kim; Seong-Jang Kim; In-Joo Kim; Dong Uk Kim; Heeyoung Kim; Sojung Kim; Sang Hyun Ahn
Journal:  Nucl Med Mol Imaging       Date:  2014-04-23

8.  Diffuse splenic FDG uptake is predictive of clinical outcomes in patients with rectal cancer.

Authors:  Sang Yoon Kim; Chang Mo Moon; Hai-Jeon Yoon; Bom Sahn Kim; Ji Young Lim; Tae Oh Kim; A Reum Choe; Chung Hyun Tae; Seong-Eun Kim; Hye-Kyung Jung; Ki-Nam Shim; Sung-Ae Jung
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

9.  Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia.

Authors:  Jordy P Pijl; Thomas C Kwee; Riemer H J A Slart; Derya Yakar; Marjan Wouthuyzen-Bakker; Andor W J M Glaudemans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-26       Impact factor: 9.236

10.  Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.

Authors:  Hai-Jeon Yoon; Bom Sahn Kim; Chang Mo Moon; Jang Yoo; Ko Eun Lee; Yemi Kim
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.